Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ACN
6. AZN
7. ROIV
8. AAPL
9. HOOD
10. QCOM

Go back to Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer
(NASDAQ: NTRA) Delayed: 324.14 -4.04 (1.23%)
Previous Close $328.18    52 Week High $13.80 
Open $326.29    52 Week Low $6.52 
Day High $331.40    P/E N/A 
Day Low $321.21    EPS $0.00 
Volume 1,024,778